Financials
- Market Capitalization 18.43 M
- Employee 7
- Founded 2004
- CEO N/A
- Website www.lexariabioscience.com
- Headquarter Nevada, United States
- FIGI BBG000JQHT18
- Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
-0.12
Preis-Umsatz-Verhältnis
58.78
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 4577 | CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.72 USD | +0.37% | +28.30% | +70.00% | +84.41% | 19.56 M USD | ||
| 4598 | LPCN Lipocine Inc. - Common Stock | 2.24 USD | +3.23% | +7.69% | 0.00% | -22.76% | 18.47 M USD | ||
| 4600 | BIVI BioVie Inc. - Common stock | 2.44 USD | +12.96% | +25.77% | +62.67% | +93.65% | 18.40 M USD | ||
| 4608 | RADX Radiopharm Theranostics Limited American Depositary Shares | 2.28 USD | -5.39% | -8.43% | -24.75% | -58.55% | 17.97 M USD |